Close Bookmark and Share This Page

Save to Browser Favorites / Bookmarks

Ask backflip blinklist BlogBookmark Bloglines BlogMarks Blogsvine BuddyMarks BUMPzee! CiteULike Connotea del.icio.us

Digg diigo DotNetKicks DropJack dzone Facebook Fark Faves Friendsite folkd.com Furl Google

Jamespot Jeqq Kaboodle kirtsy linkaGoGo LinkedIn Ma.gnolia Mister Wong Mixx MySpace Netvouz Newsvine

oneview OnlyWire PlugIM Propeller Reddit Segnalo Shoutwire Simpy Slashdot Surphace Sphinn Spurl

Squidoo StumbleUpon Technorati ThisNext Twitter Webride Windows Live Yahoo!

Email This to a Friend

  Link HTML: 

 Permalink: 

 If you like this then please subscribe to the RSS Feed.

Powered by Bookmarkify™

More »

RXi Pharmaceuticals Corporation (NASDAQ:RXII) witnessed the correction of 9.38% and closed at $1.16 whereas overall traded volume stood at 1.67 million shares for the day. The current market price is 20.66% less than its last 50 days simple moving average. The RSI value of 37.02 times depicts that the current share value is in overbought level.

Poniard Pharmaceuticals, Inc. (NASDAQ:PARD) dropped by 5.43% to close at $0.35 with total traded volume of 1.50 million shares in the last trading session. The company maintains strong short term liquidity position with current ratio of 3.23 times.

ABIOMED, Inc. (NASDAQ:ABMD) closed at $15.09 after plunging by 4.97% whereas traded volume stood at 3.41 million shares for the day. Its outstanding share stood at 37.85 million. Its total market capitalization arrived at $571.16 million.

By,

Martin Hammond